1University of Helsinki and Helsinki University Hospital, Department of Obstetrics and Gynecology, Helsinki, Finland
2Folkhälsan Research Center, Biomedicum, Helsinki, Finland
3EPID Research Oy, Espoo, Finland
4National Institute for Health and Welfare, Helsinki, Finland
5Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Division of Family Medicine, Stockholm, Sweden.
Address correspondence to: Tomi S. Mikkola, MD, PhD, Helsinki University Hospital, Department of Obstetrics and Gynaecology, Haartmaninkatu 2, PO Box 140, FIN-00029 HUS, Helsinki, Finland. E-mail: [email protected]
Received 6 July, 2017
Revised 2 October, 2017
Accepted 2 October, 2017
Funding/support: This work was supported by grants from the Päivikki and Sakari Sohlberg Foundation, the Emil Aaltonen Foundation, the Finnish Medical Foundation, Finska Läkaresällskapet, the Orion Farmos Research Foundation, the Paavo Nurmi Foundation, Jane and Aatos Erkko Foundation and a Finnish governmental grant for research on health sciences.
Financial disclosure/conflicts of interest: TSM has been a speaker and/or received consulting fees from Mylan and Novo Nordisk. HS-P has been a speaker for Mylan and received funding for congress trips from Mylan, Finox Biotech, and MSD. PR-S has received funding for congress trips from Johnson & Johnson and Olympus. PV and FH work for EPID Research. EPID Research is a company that performs financially supported studies to several pharmaceutical companies. Other authors report no conflicts of interest.
